Citius Oncology, Inc.
CTOR
$0.94
$0.011.17%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -46.06M | -42.51M | -23.64M | -24.76M | -26.58M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 179.40K | 2.29M | 573.40K | -- | -- |
| Total Other Non-Cash Items | 17.55M | 12.47M | 11.53M | 9.38M | 8.63M |
| Change in Net Operating Assets | 8.95M | 11.07M | -1.31M | 9.89M | 18.08M |
| Cash from Operations | -19.39M | -16.68M | -12.85M | -5.49M | 126.40K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -12.75M | -10.75M | -10.15M | -5.75M | -5.00M |
| Cash from Investing | -12.75M | -10.75M | -10.15M | -5.75M | -5.00M |
| Total Debt Issued | 9.64M | -- | -- | -- | 3.80M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 40.02M | 30.29M | 30.29M | 15.17M | -- |
| Repurchase of Common Stock | -61.90K | -61.90K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -892.60K | -169.30K | -- | -- | 1.07M |
| Cash from Financing | 48.70M | 30.06M | 30.29M | 15.17M | 4.87M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 16.56M | 2.63M | 7.30M | 3.92M | 100.00 |